Yongping Xue

516 total citations
9 papers, 360 citations indexed

About

Yongping Xue is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yongping Xue has authored 9 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Yongping Xue's work include Bladder and Urothelial Cancer Treatments (6 papers), Ferroptosis and cancer prognosis (4 papers) and Urinary and Genital Oncology Studies (2 papers). Yongping Xue is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Ferroptosis and cancer prognosis (4 papers) and Urinary and Genital Oncology Studies (2 papers). Yongping Xue collaborates with scholars based in China, United States and Sweden. Yongping Xue's co-authors include Anwei Liu, Shuxiong Zeng, Chuanliang Xu, Qiao Xiong, Yinghao Sun, Zhensheng Zhang, Xing He, Liping Tong, Zeyu Yang and Xin Lü and has published in prestigious journals such as Journal of Cellular Physiology, International Journal of Biological Macromolecules and Cell Death and Disease.

In The Last Decade

Yongping Xue

9 papers receiving 357 citations

Peers

Yongping Xue
Yongping Xue
Citations per year, relative to Yongping Xue Yongping Xue (= 1×) peers Sayuri Ohnishi

Countries citing papers authored by Yongping Xue

Since Specialization
Citations

This map shows the geographic impact of Yongping Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongping Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongping Xue more than expected).

Fields of papers citing papers by Yongping Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongping Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongping Xue. The network helps show where Yongping Xue may publish in the future.

Co-authorship network of co-authors of Yongping Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Yongping Xue. A scholar is included among the top collaborators of Yongping Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongping Xue. Yongping Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Xiong, Qiao, Anwei Liu, Qian Ren, et al.. (2020). Cuprous oxide nanoparticles trigger reactive oxygen species-induced apoptosis through activation of erk-dependent autophagy in bladder cancer. Cell Death and Disease. 11(5). 366–366. 46 indexed citations
2.
Qin, Yingyi, Hedong Han, Yongping Xue, et al.. (2020). Comparison and trend of perioperative outcomes between robot-assisted radical prostatectomy and open radical prostatectomy: nationwide inpatient sample 2009-2014. International braz j urol. 46(5). 754–771. 7 indexed citations
3.
Liu, Fei, Anwei Liu, Xin Lü, et al.. (2019). Dysbiosis signatures of the microbial profile in tissue from bladder cancer. Cancer Medicine. 8(16). 6904–6914. 96 indexed citations
4.
Zeng, Shuxiong, Anwei Liu, Lihe Dai, et al.. (2019). Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms. BMC Cancer. 19(1). 604–604. 42 indexed citations
5.
Xue, Yongping, Liping Tong, Anwei Liu, et al.. (2019). Tumor‑infiltrating M2�macrophages driven by specific genomic alterations are associated with prognosis in bladder cancer. Oncology Reports. 42(2). 581–594. 96 indexed citations
6.
Yang, Zeyu, Anwei Liu, Qiao Xiong, et al.. (2019). Prognostic value of differentially methylated gene profiles in bladder cancer. Journal of Cellular Physiology. 234(10). 18763–18772. 10 indexed citations
7.
Liu, Anwei, Yongping Xue, Fei Liu, et al.. (2019). Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy. Cancer Biomarkers. 26(3). 281–289. 8 indexed citations
8.
Zeng, Shuxiong, Yongping Xue, Junjie Zhao, et al.. (2018). Total parenteral nutrition versus early enteral nutrition after cystectomy: a meta-analysis of postoperative outcomes. International Urology and Nephrology. 51(1). 1–7. 14 indexed citations
9.
Liu, Anwei, Shuxiong Zeng, Xin Lü, et al.. (2018). Overexpression of G2 and S phase-expressed-1 contributes to cell proliferation, migration, and invasion via regulating p53/FoxM1/CCNB1 pathway and predicts poor prognosis in bladder cancer. International Journal of Biological Macromolecules. 123. 322–334. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026